Back to search

University of Southampton

Cardiovascular risk after liver transplantation

Abstract

dc:description.abstract

<p>Using data from patient records, I assessed the prevalence of risk factors for cardiovascular disease after liver transplant and compared these to a non-transplant population. The data was to examine the effect of switching immunosuppression from cyclosporin to tacrolimus upon cardiovascular risk. Clinical trials involving liver transplant recipients have examined the role of endothelin, renin-aldosterone and arterial stiffness in the development of hypertension, the efficacy of different antihypertensive drugs and the value of brain natriuretic peptide (BNP) as a potential screening tool for left ventricular impairment in hypertensive patients. </p> <p>The predicted 10 - year probability of coronary heart disease (CHD) increased after liver transplant and was higher than a matched non-transplant population. Hypertension and hypercholesterolaemia were the most common risk factors for CHD. Tacrolimus was associated with a reduced prevalence of cardiovascular risk factors compared with cyclosporin and switching to tacrolimus can reduce blood pressure, weight and serum cholesterol. Increases in arterial stiffness and plasma endothelium-1 were implicated in the development of hypertension during the first 6 months. Amlodipine was optimum first line treatment of hypertension, with Iisinopril being superior to bisoprolol was second-line treatment. BNP levels were raised in transplant recipients, particularly those with hypertension. Hyperuricaemia is common after liver transplantation and is associated with an increased predicted risk of CHD.</p> <p>CHD risk rises after liver transplantation. It is likely that this will lead to an increase in post-transplant morbidity and mortality form cardiovascular disease, but this is not apparent by 5 years. Management of hypertension, hypercholesterolaemia and attention to weight gain after transplant are important to reduce the burden of post-transplant cardiovascular disease.</p>

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Southampton
Year dc:date.issued
2003

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Neal, David A. J

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Neal, David A. J. Cardiovascular risk after liver transplantation. doctoral thesis, University of Southampton, 2003.